XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.23.3

Contributed Equity | 12 Months Ended
--- | ---
Jun. 30, 2023
Statement [LineItems] |
Contributed Equity | NOTE 20. CONTRIBUTED EQUITY
|  | Note |  |  | Consolidated |
|  | June 30, 2023 A$ |  |  | June 30, 2022 A$ |
Fully paid ordinary shares |  |  | 20 | (a) |  |  | 436,610,249 |  |  |  | 357,745,803 |
Options over ordinary shares – listed |  |  |  |  |  |  | 9,661,954 |  |  |  | 9,661,954 |
|  |  |  |  |  |  | 446,272,203 |  |  |  | 367,407,757 |
In November 2019, the shareholders approved a 10 to 1 share consolidation during the 2019 Annual General Meeting. Refer to notes 15 and 16 for impact of the 10 to 1 share consolidation to US warrants and convertible notes, respectively. (a) Ordinary Shares
|  |  |  |  | June 30, 2023 |  |  | June 30, 2022 |
|  | Note |  |  | No. |  |  | A$ |  |  | No. |  |  | A$ |
At the beginning of reporting period |  |  |  |  |  |  | 866,239,815 |  |  |  | 357,745,803 |  |  |  | 748,152,935 |  |  |  | 303,760,351 |
Shares issued during the year |  |  | 20 | (b) |  |  | 308,010,583 |  |  |  | 80,082,752 |  |  |  | 102,769,866 |  |  |  | 53,440,330 |
Transaction costs relating to share issues |  |  |  |  |  |  | — |  |  |  | (4,145,006 | ) |  |  | — |  |  |  | (2,386,919 | )
Exercise of performance rights (shares issued during the year) |  |  | 20 | (b) |  |  | 6,908,380 |  |  |  | 1,881,688 |  |  |  | 3,200,000 |  |  |  | 872,250 |
Conversion of Convertible Notes (shares issued during the period) |  |  | 20 | (b) |  |  | 6,147,431 |  |  |  | 1,045,012 |  |  |  | 12,117,014 |  |  |  | 2,059,791 |
At reporting date |  |  |  |  |  |  | 1,187,306,209 |  |  |  | 436,610,249 |  |  |  | 866,239,815 |  |  |  | 357,745,803 |
(b) Shares issued
|  |  |  |  | Issue Price |  |  | Total |
2023 Details |  | Number |  |  | A$ |  |  | A$ |
Share issued under Retail Entitlement Offer |  |  | 47,145,743 |  |  |  | 0.26 |  |  |  | 12,257,894 |
Shares issued under Institutional Placement |  |  | 260,864,840 |  |  |  | 0.26 |  |  |  | 67,824,858 |
Performance rights exercised (transfer from share-based payment reserve) |  |  | 6,908,380 |  |  |  | 0.27 |  |  |  | 1,881,688 |
Convertible Notes exercised |  |  | 6,147,431 |  |  |  | 0.17 |  |  |  | 1,045,012 |
|  |  | 321,066,394 |  |  |  |  |  |  |  | 83,009,452 |
|  |  |  |  | Issue Price |  |  | Total |
2022 Details |  | Number |  |  | A$ |  |  | A$ |
Shares issued under Securities Purchase Plan |  |  | 13,799,149 |  |  |  | 0.52 |  |  |  | 7,175,557 |
Share placement July 2021 |  |  | 88,970,717 |  |  |  | 0.52 |  |  |  | 46,264,773 |
Performance rights exercised (transfer from share-based payment reserve) |  |  | 3,200,000 |  |  |  | 0.27 |  |  |  | 872,250 |
Convertible Notes exercised |  |  | 12,117,014 |  |  |  | 0.17 |  |  |  | 2,059,791 |
|  |  | 118,086,880 |  |  |  |  |  |  |  | 56,372,371 |
* | All number of shares have been adjusted for the 10 to 1 share consolidation.
Ordinary shares Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have no par value and the company does not have a limited amount of authorized capital. On a show of hands every member present at a meeting in person or by proxy shall have one vote and upon a poll each share shall have one vote. Options Information relating to the Company’s Global Employee Share Option Plan, including details of options issued, exercised and lapsed during the year and options outstanding at the end of the reporting period, is set out in note 32. Unlisted Options
Expiration Date |  | Exercise Price |  |  | Number |
August 4, 2025 |  | $ | 0.248 |  |  |  | 847,600 |
Total |  |  |  |  |  |  | 847,600 |
* | 1 American Depository Shares (ADS) listed on NASDAQ equals 10 ordinary shares listed on ASX thus the number of warrants on issue have been grossed up and their exercise prices have been adjusted accordingly in the above table to be comparable.
Share buy-back There is no current on-market share buy-back. Capital risk management The consolidated entity’s objectives when managing capital are to safeguard its ability to continue as a going concern, so that they can continue to provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure to reduce the cost of capital. In order to maintain or adjust the capital structure, the consolidated entity may adjust the amount of dividends paid to shareholders, return capital to shareholders, issue new shares or sell assets to reduce debt. The consolidated entity would look to raise capital when an opportunity to invest in a business or company was seen as value adding relative to the current parent entity’s share price at the time of the investment. The consolidated entity is not actively pursuing additional investments in the short term as it continues to integrate and grow its existing businesses in order to maximize synergies.

X
- Definition The disclosure of contributed equity. + References No definition available. + Details
Name: | immp_DisclosureOfContributedEquityExplanatory
Namespace Prefix: | immp_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | immp_StatementLineItems
Namespace Prefix: | immp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration